A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)
NCT07645248
·
clinicaltrials.gov ↗
PHASE3
Phase
RECRUITING
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Asthma
Interventions
DRUG:
HFA-152a
DRUG:
HFA-134a
Sponsor
GlaxoSmithKline